KEVIN CHAUSSEE: Open Payments
NPI 1962424440 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 65 payments from 10 companies in 2025. Trend: 2023 $496 · 2024 $957 · 2025 $884
Food & beverage: $723Education: $161
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $169 |
| E.R. Squibb & Sons, L.L.C. | 14 | $167 |
| Lilly USA, LLC | 19 | $147 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $78 |
| Janssen Biotech, Inc. | 3 | $51 |
| UCB, Inc. | 1 | $36 |
| Amgen Inc. | 2 | $30 |
| GENZYME CORPORATION | 1 | $21 |
Products named: SKYRIZI, Sotyktu, DUPIXENT, EBGLYSS, COSENTYX, TREMFYA, Bimzelx, OTEZLA.
Industry payments across ND — which companies pay providers there.
